The introduction of “addiction vaccines” has brought with it a belief that we have the potential to cure addicts before they have ever tried a drug. Proponents of addiction vaccines hold that they will: prevent children from becoming addicted to drugs in the future, allow addicts to easily and safely stop using drugs, and potentially lower the social and economic costs of addiction for society at large.
However, it is critical to be aware of the limitations and risks — ethical and physical — of introducing these vaccines into mainstream medical care.
Access to the full article is available to SfN members.
Neuronline is a benefit of SfN membership. Renew your membership now to make sure you don’t lose access.
About the Contributor
Tabitha Moses, MS, is an administrative and research coordinator at Lehman College, CUNY, as well as a research affiliate at the National Core for Neuroethics at the University of British Columbia.
.jpg?h=423&w=750&la=en&hash=FC039CACB95D991B05733709F27CAA28CB3C17E3)
0 of 5 articles left
Login
or
Become a Member
to unlock content
